PMDA Posts MHLW Instructions to Revise Precautions for Use (Drugs), Dated August 24 and 25, 2026
使用上の注意の改訂指示通知（医薬品）2026年8月24日付及び2026年8月25日付（厚生労働省より発出）を掲載しました
Published: 2026-08-25 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-26
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Pharmaceuticals and Medical Devices Agency (PMDA) has posted notices instructing revisions to the 'Precautions for Use' sections for certain drugs, issued by the Ministry of Health, Labour and Welfare (MHLW) and dated August 24, 2026 and August 25, 2026. This is a government safety announcement relating to drug labeling precautions. The specific drugs and the content of the revisions are not detailed in the provided metadata.
Business Impact
Companies handling the affected drugs may need to review and update product labeling or precaution information to reflect the revised instructions.
Recommended Action
Consider reviewing the official PMDA source and the underlying MHLW notices to identify the specific drugs and required precaution revisions.